Analyst Ratings for NeuBase Therapeutics (NBSE)

NBSE Rating Summary

  |   Expand Research on NBSE
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/21/2022 Oppenheimer Hartaj Singh Downgrade Perform
(Outperform)		 N/A
(N/A)		 0.29
(0.38)		 31.03% Details
10/18/2022 RBC Capital Brian Abrahams Downgrade Sector Perform
(Outperform)		 1.00
(12.00)		 0.31
(0.38)		 22.58% Details